First Survey of SNPs in TMEM154, TLR9, MYD88 and CCR5 Genes in Sheep Reared in Italy and their Association with Resistance to SRLVs Infection

Maedi-visna virus (MVV) and caprine arthritis encephalitis virus (CAEV), referred to as small ruminant lentiviruses (SRLVs), belong to the genus Lentivirus of the Retroviridae family. SRLVs infect both sheep and goats, causing significant economic losses and animal welfare damage. Recent findings suggest an association between serological status and allelic variants of different genes such as TMEM154, TLR9, MYD88 and CCR5. The aim of this work was to investigate the role of specific polymorphisms of these genes in SRLVs infection in some sheep flocks in Italy. In addition to those already known, novel variants in the TMEM154 (P7H, I74V, I105V) gene were detected in this study. The risk of infection was determined finding an association between the serological status and polymorphisms P7H, E35K, N70I, I74V, I105V of TMEM154, R447Q, A462S and G520R in TLR9 gene, H176H* and K190K* in MYD88 genes, while no statistical association was observed for the 4-bp deletion of the CCR5 gene. Since no vaccines or treatments have been developed, a genetically based approach could be an innovative strategy to prevent and to control SRLVs infection. Our findings are an important starting point in order to define the genetic resistance profile towards SRLVs infection.

Prevalence and risk factors associated with Maedi-Visna infection in sheep in the State of Maranhão, Brazil

In order to determine Maedi-Visna virus (MVV) seroprevalence and risk factors associated with infection in sheep, 445 animals of both sexes and different ages were tested using the Agarose Gel Immunodiffusion technique (IDGA). The animals were divided into two groups: group 1 composed of exhibition animals (n=70) and group 2 composed of animals from properties from the north, east and central mesoregions of the state of Maranhão (n=375). The general prevalence of MVV infection was 2.02%; 1.42% in group 1 and 2.13% in group 2. In the north mesoregion the prevalence was 2.20%, while a total of 40% of the animals living in municipalities for MVV. It was observed that 1.15% of males and 2.23% of females were seropositive (p> 0.20). Regarding breeds, the Dorper (1.66%); Santa Inês (1.67%); White Dorper (33.33%) and Texel (4.34%) were the most affected. This was the only variable among all the risk factors studied that had a significant association in multivariate analysis (p <0.05). MVV infection is present regardless of the purpose of breeding, and the animals are exposed to the same risk of infection. This demonstrates the need to implement public policies for the prevention, control, and eradication of this disease.

Ovine Progressive Pneumonia: Diagnosis and Seroprevalence in the South of Sonora, Mexico

Ovine progressive pneumonia (OPP) is the most severe presentation of small ruminant lentivirus (SRLV) infection known as Maedi-Visna. Serological evidence in Mexico of the presence of this lentivirus was published in 1986. After that, studies revealed that SRLVs have a broad distribution in Mexico by detecting antibodies or/and molecular tests; however, a descriptive case of the disease has not been published. This work’s objective was to describe the diagnosis of a case of OPP through lesion description, serology, and molecular test. The histopathological study showed that lymph follicular hyperplasia, interstitial pneumonia, and smooth muscle hyperplasia were presented. The serological test demonstrated specific antibodies against the Maedi-Visna virus, and PCR analysis demonstrated a positive outcome. These results include the criteria for the diagnosis of OPP. The serological prevalence of this disease is presented, contributing to the knowledge of the ecology of this disease in the world. This work is the first case report of ovine progressive pneumonia in Mexico and evidence of seroprevalence in sheep herds from Sonora, Mexico.

Maedi-visna virus Vif protein uses motifs distinct from HIV-1 Vif to bind zinc and cofactor required for A3 degradation

The mammalian apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3 (APOBEC3 or A3) family of cytidine deaminases restrict viral infections by mutating viral DNA and impeding reverse transcription. To overcome this antiviral activity, most lentiviruses express a viral accessory protein called Vif, which recruits A3 proteins to Cullin-RING E3 ubiquitin ligases such as Cul5 for ubiquitylation and subsequent proteasomal degradation. While Vif proteins from primate lentiviruses like HIV-1 utilize the transcription factor CBFβ as a non-canonical cofactor to stabilize the complex, maedi-visna virus (MVV) Vif hijacks cyclophilin A (CypA) instead. Since CBFβ and CypA are both highly conserved among mammals, the requirement for two different cellular cofactors suggests that these two A3-targeting Vif proteins have different biochemical and structural properties. To investigate this topic, we used a combination of in vitro biochemical assays and in vivo A3 degradation assays to study motifs required for MVV Vif to bind zinc ion, Cul5, and the cofactor CypA. Our results demonstrate that while some common motifs between HIV-1 Vif and MVV Vif are involved in recruiting Cul5, different determinants in MVV Vif are required for cofactor binding and stabilization of the E3 ligase complex, such as the zinc-binding motif and N- and C-terminal regions of the protein. Results from this study advance our understanding of the mechanism of MVV Vif recruitment of cellular factors and the evolution of lentiviral Vif proteins.

Bioactive monolaurin as an antimicrobial and its potential to improve the immune system and against COVID-19: a review

Monolaurin is monoacylglycerol which is a bioactive lipid since it can affect the human biological systems. This review discusses the bioactive properties of monolaurin, especially its role as an antibacterial, immune system enhancement, and its ability as an antiviral so that it has the potential to fight against various viral attacks. Monolaurin can act as an antibacterial in inhibiting the growth of several pathogenic bacteria, especially gram-positive bacteria. Monolaurin is known to be able to enhance the immune system through modulation of various immune systems, controlling pro-inflammatory cytokines, activating and attracting leukocytes to the site of infection. Monolaurin can also act as an antiviral, especially against enveloped viruses, such as Maedi-visna virus, vesicular stomatitis, herpes simplex-1, measles, HIV, cytomegalovirus, influenza, and corona. Monolaurin inhibits the virus through the mechanism of the disintegration of the viral membrane, prevents binding of the viral protein to the host-cell membrane, inhibits the process of assembling the viral RNA, and the process of virus maturation in the replication cycle. Therefore monolaurin has the potential for human consumption to boost the immune system and ward off various virus attacks, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is the cause of COVID-19 which became a pandemic in the world.